Nisa Investment Advisors, LLC Prometheus Biosciences, Inc. Transaction History

Nisa Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$103.46 - $126.29 $94,148 - $114,923	910 Added 355.47%	1,166 $125,000
Q4 2022 Feb 02, 2023	BUY	$36.06 - $117.21 $288 - $937	8 Added 3.23%	256 $28,000
Q3 2022 Nov 07, 2022	BUY	$28.17 - $59.01 $619 - $1,298	22 Added 9.73%	248 $13,000
Q2 2022 Aug 03, 2022	SELL	$22.39 - $38.94 $13,523 - $23,519	-604 Reduced 72.77%	226 $6,000
Q1 2022 Apr 29, 2022	BUY	$30.13 - $50.0 $25,007 - $41,500	830 New	830 $31,000

29.6K

Ticker RXDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,904,100
Description
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.